Los puntos clave no están disponibles para este artículo en este momento.
The 5-year results of this trial showed that adjuvant therapy with dabrafenib plus trametinib resulted in longer relapse-free survival and distant metastasis-free survival than placebo among patients with
Long et al. (Wed,) studied this question.